CN105749189A - Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of traditional Chinese medicine composition - Google Patents
Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of traditional Chinese medicine composition Download PDFInfo
- Publication number
- CN105749189A CN105749189A CN201610321722.6A CN201610321722A CN105749189A CN 105749189 A CN105749189 A CN 105749189A CN 201610321722 A CN201610321722 A CN 201610321722A CN 105749189 A CN105749189 A CN 105749189A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 201000001429 Intracranial Thrombosis Diseases 0.000 title claims abstract description 31
- 206010008132 Cerebral thrombosis Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229940079593 drug Drugs 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 241001057584 Myrrha Species 0.000 claims description 24
- 239000009636 Huang Qi Substances 0.000 claims description 17
- 241000237636 Pheretima Species 0.000 claims description 17
- 241000522620 Scorpio Species 0.000 claims description 17
- 239000009490 scorpio Substances 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 16
- 241000131808 Scolopendra Species 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 10
- 239000012535 impurity Substances 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000006260 foam Substances 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 4
- 239000000779 smoke Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000002893 slag Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 34
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 13
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 208000007536 Thrombosis Diseases 0.000 abstract description 5
- 241000258920 Chilopoda Species 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241001481692 Mesobuthus martensii Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 240000001398 Typha domingensis Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 238000002481 ethanol extraction Methods 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010013887 Dysarthria Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 208000008630 Sialorrhea Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000178320 Vaccaria pyramidata Species 0.000 description 2
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 210000002551 anterior cerebral artery Anatomy 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 208000026473 slurred speech Diseases 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010050012 Bradyphrenia Diseases 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008589 Choking Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 206010022773 Intracranial pressure increased Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000004004 carotid artery internal Anatomy 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003657 middle cerebral artery Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for treating cerebral thrombosis and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition comprises the following components in parts by weight: 2-6 parts of dried buthus martensii, 6-14 parts of centipede, 2-10 parts of earthworm, 5-15 parts of angelica sinensis, 12-20 parts of monkshood, 10-18 parts of myrrh, 10-22 parts of radix aconiti lateralis preparata, 7-13 parts of fructus evodiae, 4-13 parts of curcuma zedoary, 4-9 parts of cattail pollen, 3-12 parts of ligusticum wallichii, 6-12 parts of honeysuckle, 5-12 parts of astragalus membranaceus, 3-10 parts of tree peony bark, 15-25 parts of common peony roots and 8-15 parts of liquorice. Due to scientific computability of the components according to traditional Chinese medicine theories, and combination of the medicines, the traditional Chinese medicine composition provided by the invention has the effects of dredging collaterals and activating blood, tonifying spleen and nourishing qi, dissolving and removing thrombus, and the like, active components of the traditional Chinese medicines can be obtained through ethanol extraction and water decoction, and the traditional Chinese medicine composition is definite in treatment effect, free of side effect and remarkable in effect.
Description
Technical field
The invention belongs to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition treating cerebral thrombosis and system thereof
Preparation Method.
Background technology
Cerebrovascular disease is to currently exist in class commonly encountered diseases and the frequently-occurring disease in mid-aged population, has a strong impact on
The life of people also threatens human health.Cerebrovascular disease by its character can be divided into hemorrhagic apoplexy and
Ischemic cerebrovascular, ischemic cerebrovascular is the most common clinically, accounts for Changes of Patients With Cerebrovascular Diseases
70%-80%.Cerebral thrombosis is the modal type of cerebral infarction, belongs to ischemic cerebrovascular, is cerebral arteries master
Dry or cortical branches atherosclerosis causes Aldosterone, luminal stenosis inaccessible and thrombosis, causes brain office
Portion's Oligemia or blood supply are interrupted, and brain tissue ischemia anoxia causes softening the focal nervous system disease of downright bad appearance
Shape.Once had before morbidity that limbs are numb, it is ineffective to move, the sign such as slurred speech, dizziness and blurred vision.
Occurring time often in sleep or morning, patient activity is unable or stiff, speaks ambiguous, severe patient meeting
Hemiplegia or aphasia, drink water to send out and choke.
The modal cause of disease of cerebral thrombosis is arteriosclerosis, and due to cerebral arteriosclerosis, official jargon inner membrance is coarse,
Tube chamber narrows, and under certain conditions, blood pressure reduces, blood flow slows down or blood viscosity increases, platelet
Under the effect of the factors such as aggregation enhancing, thrombin coagulation in bulk in tube chamber, form thrombosis, make blood vessel
Obturation, blood flow interrupt, from but the brain tissue ischemia in blood vessel blood supply district, anoxia, softening, necrosis and fall ill.
The formation of cerebral thrombosis can occur at any one section of Ink vessel transfusing, clinically with internal carotid artery, anterior cerebral artery and
The thrombosis that the branch of middle cerebral artery is formed is more typically.Patient often shows central hemiplegia, facial paralysis and offside
Limbs are felt to go down.Most patient sanity, headache, vomiter are rare；But anterior cerebral artery or big
When the blocking of brain medium-sized artery trunk forms large area blocking, patient there will be the disease of disturbance of consciousness and increased intracranial pressure
Shape.Vertebral basilar system thrombosis, the motion of the most common dizziness, Nausea and vomiting, intercrossing and sensation
Obstacle, dysphagia, symptoms such as choking sent out by drinking-water.
Western medical treatment can be used, owing to Western medicine action target spot is single, for every kind of disease currently for above-mentioned disease
Become multi-medicament synergy such as using thrombolytic, neuroprotective, antiinflammatory, nutrition, costly, west in addition
Medical instrument has side effect, and gastrointestinal Liver and kidney can cause damage in various degree.Therefore having takes stopgap measures consolidates advantage
Chinese traditional treatment mode is widely used in cerebral thrombus patient, although achieves certain curative effect, but still there is curative effect
Slowly, the problem of the length course for the treatment of, therefore Chinese traditional treatment cerebral thrombosis disease needs reinforcement research.
Summary of the invention
The technical problem to be solved is: for the deficiency of the problems referred to above, it is provided that one treats brain blood
The Chinese medicine composition of bolt, this Chinese medicine composition determined curative effect, has no side effect, treats cerebral thrombosis and have notable effect
Really.
For solving above-mentioned technical problem, the technical scheme is that
A kind of Chinese medicine composition treating cerebral thrombosis, includes following component in parts by weight: Scorpio 2-6 part,
Scolopendra 6-14 part, Pheretima 2-10 part, Radix Angelicae Sinensis 5-15 part, Radix Aconiti 12-20 part, Myrrha 10-18 part, attached
Sub-10-22 part, Fructus Evodiae 7-13 part, Rhizoma Curcumae 4-13 part, Pollen Typhae 4-9 part, Rhizoma Chuanxiong 3-12 part, gold silver
Flower 6-12 part, Radix Astragali 5-12 part, Cortex Moutan 3-10 part, Radix Paeoniae Rubra 15-25 part and Radix Glycyrrhizae 8-15 part.
As the preferred technical scheme of one, include following component in parts by weight: Scorpio 3-5 part, Wu
Centipede 8-12 part, Pheretima 5-8 part, Radix Angelicae Sinensis 8-13 part, Radix Aconiti 15-18 part, Myrrha 13-16 part, Radix Aconiti Lateralis Preparata
14-20 part, Fructus Evodiae 9-12 part, Rhizoma Curcumae 7-12 part, Pollen Typhae 5-8 part, Rhizoma Chuanxiong 5-10 part, Flos Lonicerae
8-11 part, Radix Astragali 6-10 part, Cortex Moutan 5-8 part, Radix Paeoniae Rubra 18-23 part and Radix Glycyrrhizae 10-14 part.
To be solved by this invention another technical problem is that: provides a kind of Chinese medicine composition treating cerebral thrombosis
Preparation method, this preparation method is simple, easy to operate, the Chinese medicine composition determined curative effect of gained, without secondary
Effect, treatment cerebral thrombosis have remarkable result.
For solving above-mentioned technical problem, the technical scheme is that
The preparation method of a kind of Chinese medicine composition treating cerebral thrombosis, described preparation method comprises the following steps:
Step 1: first by Chinese crude drug Scorpio, Scolopendra, Pheretima, Radix Angelicae Sinensis, Radix Aconiti, Myrrha, Radix Aconiti Lateralis Preparata, Wu Zhu
Cornel, Rhizoma Curcumae, Pollen Typhae, Rhizoma Chuanxiong, Flos Lonicerae, the Radix Astragali, Cortex Moutan, Radix Paeoniae Rubra and Radix Glycyrrhizae are respectively washed, remove impurity,
It is dried, then according to weight portion weighs successively, adds relative to Chinese crude drug weight 8-12 times after pulverizing
The ethanol that volumetric concentration is 40-80%, impregnate 1-2h, reflux, extract, 2-3 time, merging filtrate, retain filter
Slag, obtains alcohol extraction concentrated solution；
Step 2: by adding water in above-mentioned filtering residue, soak 15-30 minute, decoct 2 times, merge decoction liquor,
Obtain water extracting liquid；
Step 3: the water extracting liquid mix homogeneously that alcohol extraction concentrated solution step 1 obtained and step 2 obtain,
It is concentrated to give powdered extract, pulverizes, sieve, add adjuvant and make Chinese medicine.
As the technical scheme of a kind of improvement, first described Myrrha is picked up clean remove impurity, is broken into little
Grain or corase meal, then Rhizoma Cyperi powder is placed in pot first with slow fire fry, after fry with high heat, place into after making popular
Myrrha stirs, and fries and rises to dense smoke, in taupe, foam crisp, takes out, dry in the air cool.
As the technical scheme of a kind of improvement, alcohol extraction concentrated solution and the mixing of water extracting liquid in described step 3
Temperature is 50-65 DEG C.
After have employed technique scheme, the invention has the beneficial effects as follows:
Chinese medicine composition of the present invention selects Scorpio, Scolopendra, Pheretima, Radix Angelicae Sinensis, Radix Aconiti, Myrrha, Radix Aconiti Lateralis Preparata, Wu
The Fructus Evodiae, Rhizoma Curcumae, Pollen Typhae, Rhizoma Chuanxiong, Flos Lonicerae, the Radix Astragali, Cortex Moutan, Radix Paeoniae Rubra and 16 Chinese crude drug systems of Radix Glycyrrhizae
Become.Wherein Scorpio property is flat, acrid in the mouth, poisonous, returns Liver Channel, has endogenous wind stopping spasmolytic, dispersing pathogen accumulation, and dredging collateral is only
Effect of pain；Scolopendra is warm in nature, salty in the mouth, pungent, poisonous, returns liver, spleen, lung meridian, has relieving spasm by calming endogenous wind, attacks
Poison eliminating stagnation, effect of removing obstruction in the collateral to relieve pain；Pheretima is cold in nature, salty in the mouth；Return liver, spleen, bladder warp；There is heat clearing away fixed
Frightened, dredging collateral, suppressing the hyperactive liver, effect of cough-relieving；Radix Angelicae Sinensis is warm in nature, sweet in the mouth, pungent；Return liver, the heart, spleen channel；Have
Replenishing and activating blood, effect of menstruction regulating and pain relieving；Radix Aconiti property heat, acrid in the mouth, hardship；Very toxic；GUIXIN, liver, kidney,
Spleen channel.There is expelling wind and removing dampness, antalgic.No mild in medicine property, bitter in the mouth is nontoxic.Return liver, spleen, the heart, kidney
Warp；There is promoting blood circulation to remove blood stasis, effect of circulation of qi promoting relaxing muscles and tendons；Radix Aconiti Lateralis Preparata is sweet, acrid in the mouth, the hottest, poisonous, GUIXIN,
Kidney, spleen channel, have recuperating depleted YANG and rescuing the patient from collapse, mend fire supporing yang, effect of dispersing cold for relieving pain；Fructus Evodiae is pungent, bitter in the mouth,
Heat；Slightly poisonous；Return liver, spleen, stomach, kidney channel.There is dispersing cold for relieving pain, stopping nausea and vomiting by lowering the adverse flow of QI, the merit of supporing yang antidiarrheal
Effect.Rhizoma Curcumae is warm in nature, bitter in the mouth, pungent；Return liver, spleen channel.There is removing blood stasis circulation of qi promoting, effect of removing food stagnancy pain relieving；Pu
Huang Xingping, sweet in the mouth；Return liver, pericardium channel；There is hemostasis with astringents, promoting the circulation of blood blood stasis dispelling；Rhizoma Chuanxiong is warm in nature, acrid in the mouth；
Return liver, gallbladder, pericardium channel；There is blood-activating and qi-promoting, effect of wind-expelling pain-stopping；Flos Lonicerae is cold in nature, sweet in the mouth, enters
Lung, the heart, stomach warp, have heat-clearing and toxic substances removing, antiinflammatory, effect of qi-restoratives treatment wind；The Radix Astragali is warm in nature, sweet in the mouth；Tool
Tonifying Qi and lifting yang, benefit is had to defend consolidating superficial resistance, detoxification granulation promoting, effect of diuretic detumescent；Cortex Moutan cold nature, bitter in the mouth,
Pungent, GUIXIN, liver, kidney, lung meridian, there is effect of clearing away heat and cooling blood, promoting blood circulation to remove blood stasis；Radix Paeoniae Rubra cold nature, taste
Hardship, returns Liver Channel, has clearing away heat and cooling blood, effect of blood circulation promoting and blood stasis dispelling；Radix Glycyrrhizae property is put down, and sweet in the mouth returns 12 warps.
There are the pharmacological actions such as removing toxic substances, blood stasis dispelling, pain relieving, spasmolytic.In the traditional Chinese medical science, Radix Glycyrrhizae invigorating the spleen and replenishing QI, relieving cough and moistening lung,
Emergency is detoxified, and can be in harmonious proportion hundred medicines.
The traditional Chinese medical science thinks that cerebral thrombosis is vigour loss, stagnation of blood stasis venation, or deficiency of YIN the moon gas, and the expectorant stasis of blood hands over resistance meridians,
Ailment said due to cold or exposure enters caused.Chinese medicine composition of the present invention share according to theory of Chinese medical science scientific compatibility, all medicines, has logical
The effects such as network is invigorated blood circulation, invigorating the spleen and replenishing QI, thrombolytic, logical bolt；Alcohol reflux and soak by water is used to obtain above-mentioned
The alcohol extraction active component of Chinese crude drug and water carry active component, use it for cerebral thrombus patient, determined curative effect, nothing
Side effect, effect are notable.
Detailed description of the invention
In order to make the purpose of the present invention, technical scheme and advantage clearer, below in conjunction with embodiment,
The present invention is further elaborated.Should be appreciated that specific embodiment described herein only in order to
Explain the present invention, be not intended to limit the present invention.
Embodiment 1
A kind of Chinese medicine composition treating cerebral thrombosis, counts according to weight portion (g) and includes following component: Scorpio 2g,
Scolopendra 6g, Pheretima 2g, Radix Angelicae Sinensis 5g, Radix Aconiti 12g, Myrrha 10g, Radix Aconiti Lateralis Preparata 10g, Fructus Evodiae 7g, Rhizoma Curcumae
4g, Pollen Typhae 4g, Rhizoma Chuanxiong 3g, Flos Lonicerae 6g, Radix Astragali 5g, Cortex Moutan 3g, Radix Paeoniae Rubra 15g and Radix Glycyrrhizae 8g.
Embodiment 2
A kind of Chinese medicine composition treating cerebral thrombosis, counts according to weight portion (g) and includes following component: Scorpio 3g,
Scolopendra 8g, Pheretima 5g, Radix Angelicae Sinensis 8g, Radix Aconiti 15g, Myrrha 13g, Radix Aconiti Lateralis Preparata 14g, Fructus Evodiae 9g, Rhizoma Curcumae
7g, Pollen Typhae 5g, Rhizoma Chuanxiong 5g, Flos Lonicerae 8g, Radix Astragali 6g, Cortex Moutan 5g, Radix Paeoniae Rubra 18g and Radix Glycyrrhizae 10g.
Its preparation method comprises the following steps:
Step 1: first by Chinese crude drug Scorpio, Scolopendra, Pheretima, Radix Angelicae Sinensis, Radix Aconiti, Myrrha, Radix Aconiti Lateralis Preparata, Wu Zhu
Cornel, Rhizoma Curcumae, Pollen Typhae, Rhizoma Chuanxiong, Flos Lonicerae, the Radix Astragali, Cortex Moutan, Radix Paeoniae Rubra and Radix Glycyrrhizae are respectively washed, remove impurity,
It is dried, then according to weight portion weighs successively, adds relative to Chinese crude drug weight 8 times after pulverizing
Volumetric concentration is the ethanol of 40%, impregnates 2h, reflux, extract, 2 times, merging filtrate, retains filtering residue, obtain
Alcohol extraction concentrated solution；
Step 2: by adding water in above-mentioned filtering residue, soak 15 minutes, decoct 2 times, merge decoction liquor,
To water extracting liquid；
Step 3: the water extracting liquid mix homogeneously that alcohol extraction concentrated solution step 1 obtained and step 2 obtain,
Mixing temperature is 50 DEG C, is concentrated to give powdered extract, pulverizes, crosses 120 mesh sieves, makes powder.
Wherein first Myrrha is picked up clean remove impurity, is broken into little granule or corase meal, then by Rhizoma Cyperi powder
Be placed in pot first with slow fire fry, after fry with high heat, place into Myrrha after making popular and stir, fry to dense smoke rise,
In taupe, foam crisp, take out, dry in the air cool.
Embodiment 3
A kind of Chinese medicine composition treating cerebral thrombosis, counts according to weight portion (g) and includes following component: Scorpio 4g,
Scolopendra 10g, Pheretima 7g, Radix Angelicae Sinensis 10g, Radix Aconiti 17g, Myrrha 15g, Radix Aconiti Lateralis Preparata 18g, Fructus Evodiae 11g, cowherb
Art 10g, Pollen Typhae 7g, Rhizoma Chuanxiong 8g, Flos Lonicerae 10g, Radix Astragali 9g, Cortex Moutan 7g, Radix Paeoniae Rubra 21g and Radix Glycyrrhizae
12g。
Its preparation method comprises the following steps:
Step 1: first by Chinese crude drug Scorpio, Scolopendra, Pheretima, Radix Angelicae Sinensis, Radix Aconiti, Myrrha, Radix Aconiti Lateralis Preparata, Wu Zhu
Cornel, Rhizoma Curcumae, Pollen Typhae, Rhizoma Chuanxiong, Flos Lonicerae, the Radix Astragali, Cortex Moutan, Radix Paeoniae Rubra and Radix Glycyrrhizae are respectively washed, remove impurity,
It is dried, then according to weight portion weighs successively, adds relative to Chinese crude drug weight 10 times after pulverizing
Volumetric concentration is the ethanol of 60%, impregnates 1.5h, reflux, extract, 3 times, merging filtrate, retains filtering residue,
To alcohol extraction concentrated solution；
Step 2: by adding water in above-mentioned filtering residue, soak 25 minutes, decoct 2 times, merge decoction liquor,
To water extracting liquid；
Step 3: the water extracting liquid mix homogeneously that alcohol extraction concentrated solution step 1 obtained and step 2 obtain,
Mixing temperature is 55 DEG C, is concentrated to give powdered extract, pulverizes, crosses 100 mesh sieves, adds starch, encapsulated,
Make capsule.
Embodiment 4
A kind of Chinese medicine composition treating cerebral thrombosis, counts according to weight portion (g) and includes following component: Scorpio 5g,
Scolopendra 12g, Pheretima 8g, Radix Angelicae Sinensis 13g, Radix Aconiti 16g, Myrrha 16g, Radix Aconiti Lateralis Preparata 20g, Fructus Evodiae 12g, cowherb
Art 12g, Pollen Typhae 8g, Rhizoma Chuanxiong 10g, Flos Lonicerae 11g, Radix Astragali 10g, Cortex Moutan 8g, Radix Paeoniae Rubra 23g and sweet
Grass 14g.
Its preparation method comprises the following steps:
Step 1: first by Chinese crude drug Scorpio, Scolopendra, Pheretima, Radix Angelicae Sinensis, Radix Aconiti, Myrrha, Radix Aconiti Lateralis Preparata, Wu Zhu
Cornel, Rhizoma Curcumae, Pollen Typhae, Rhizoma Chuanxiong, Flos Lonicerae, the Radix Astragali, Cortex Moutan, Radix Paeoniae Rubra and Radix Glycyrrhizae are respectively washed, remove impurity,
It is dried, then according to weight portion weighs successively, adds relative to Chinese crude drug weight 12 times after pulverizing
Volumetric concentration is the ethanol of 80%, impregnates 1h, reflux, extract, 3 times, merging filtrate, retains filtering residue, obtain
Alcohol extraction concentrated solution；
Step 2: by adding water in above-mentioned filtering residue, soak 30 minutes, decoct 2 times, merge decoction liquor,
To water extracting liquid；
Step 3: the water extracting liquid mix homogeneously that alcohol extraction concentrated solution step 1 obtained and step 2 obtain,
Mixing temperature is 60 DEG C, is concentrated to give powdered extract, pulverizes, crosses 80 mesh sieves, makes pill.
Embodiment 5
A kind of Chinese medicine composition treating cerebral thrombosis, counts according to weight portion (g) and includes following component: Scorpio 6g,
Scolopendra 14g, Pheretima 10g, Radix Angelicae Sinensis 15g, Radix Aconiti 20g, Myrrha 18g, Radix Aconiti Lateralis Preparata 22g, Fructus Evodiae 13g,
Rhizoma Curcumae 13g, Pollen Typhae 9g, Rhizoma Chuanxiong 12g, Flos Lonicerae 12g, Radix Astragali 12g, Cortex Moutan 10g, Radix Paeoniae Rubra 25g
With Radix Glycyrrhizae 15g.
Its preparation method comprises the following steps:
Step 1: first by Chinese crude drug Scorpio, Scolopendra, Pheretima, Radix Angelicae Sinensis, Radix Aconiti, Myrrha, Radix Aconiti Lateralis Preparata, Wu Zhu
Cornel, Rhizoma Curcumae, Pollen Typhae, Rhizoma Chuanxiong, Flos Lonicerae, the Radix Astragali, Cortex Moutan, Radix Paeoniae Rubra and Radix Glycyrrhizae are respectively washed, remove impurity,
It is dried, then according to weight portion weighs successively, adds relative to Chinese crude drug weight 12 times after pulverizing
Volumetric concentration is the ethanol of 70%, impregnates 1.5h, reflux, extract, 3 times, merging filtrate, retains filtering residue,
To alcohol extraction concentrated solution；
Step 2: by adding water in above-mentioned filtering residue, soak 30 minutes, decoct 2 times, merge decoction liquor,
To water extracting liquid；
Step 3: the water extracting liquid mix homogeneously that alcohol extraction concentrated solution step 1 obtained and step 2 obtain,
Mixing temperature is 60 DEG C, is concentrated to give powdered extract, pulverizes, crosses 120 mesh sieves, adds starch, encapsulated,
Make capsule.
Above-mentioned Chinese medicine composition is in preparation process, and first Chinese crude drug Myrrha is picked up clean remove impurity, smashed
Become little granule or corase meal, then Rhizoma Cyperi powder is placed in pot first with slow fire fry, after fry with high heat, after making popular
Place into Myrrha to stir, fry and rise to dense smoke, in taupe, foam crisp, take out, dry in the air cool.
Embodiment 6 Chinese medicine composition of the present invention is to cerebral thrombus patient's observation of curative effect
1. case collection: select 200 example cerebral thrombus patients, is randomly divided into experimental group and matched group, often organizes 100
Example, wherein experimental group male 65 example, women 35 example；Matched group male 73 example, women 27 example.
2. Therapeutic Method: experimental group takes the preparation that above-mentioned Chinese medicine composition is developed, and twice on the one, divides sooner or later
Take；Matched group takes XUESHUANXINMAINING, three times a day, and each two panels.
3. curative effect judgment criteria:
1) cure: transference cure, general physical exertion can be engaged in；
2) effective: symptom major part disappears, and takes care of oneself；
3) take a turn for the better: symptom major part takes a turn for the better, be relatively improved in varying degrees before treatment；
4) invalid: before and after's symptom of being admitted to hospital is not any change.
4. result of the test:
Experimental group cures 31 examples, effective 36 examples, and take a turn for the better 25 examples, invalid 8 examples, total effective rate 92%；Right
Curing 26 examples according to group, effective 31 examples, take a turn for the better 23 examples, invalid 20 examples, total effective rate 80%.Result of the test
Show that the traditional Chinese medicine composition for treating cerebral thrombosis effect using the present invention is more effective than matched group.
Embodiment 7 typical case
Case 1
Patient Wang, female, 53 years old, cerebral thrombosis was admitted to hospital, and two an eye line obscure, bradyphrenia, took after being in hospital
With above-mentioned Chinese medicinal composition capsules agent, after taking three courses for the treatment of, above-mentioned symptom disappears.Continue to take a treatment
Cheng Hou, is discharged from hospitals upon recovery, and has no recurrence in 1 year.
Case 2
Patient poplar, female, 62 years old, bimester before suddenly mouth askew, sialorrhea；Left half body inconvenient activity, speaks
Ambiguous.After taking two courses for the treatment of of Chinese medicine composition pill of the present invention, left half body can be movable, then takes
After two courses for the treatment of, walk without crutch, and lamprophonia, not sialorrhea, have no recurrence in two years.
Case 3
Patient Zhang, man, 48 years old, happened suddenly cerebral thrombosis, and right upper extremity activity is ineffective, slurred speech, through taking
After three courses for the treatment of of above-mentioned Chinese medicine composition composition powders, right upper extremity activity freely, lamprophonia, have no multiple in 1 year
Send out.
The foregoing is only presently preferred embodiments of the present invention, not in order to limit the present invention, all at this
Any amendment, equivalent and the improvement etc. made within bright spirit and principle, should be included in the present invention
Protection domain within.
Claims (5)
1. the Chinese medicine composition treating cerebral thrombosis, it is characterised in that: include following group in parts by weight
Point: Scorpio 2-6 part, Scolopendra 6-14 part, Pheretima 2-10 part, Radix Angelicae Sinensis 5-15 part, Radix Aconiti 12-20 part,
Myrrha 10-18 part, Radix Aconiti Lateralis Preparata 10-22 part, Fructus Evodiae 7-13 part, Rhizoma Curcumae 4-13 part, Pollen Typhae 4-9 part,
Rhizoma Chuanxiong 3-12 part, Flos Lonicerae 6-12 part, Radix Astragali 5-12 part, Cortex Moutan 3-10 part, Radix Paeoniae Rubra 15-25 part
With Radix Glycyrrhizae 8-15 part.
A kind of Chinese medicine composition treating cerebral thrombosis the most according to claim 1, it is characterised in that: press
Following component is included: Scorpio 3-5 part, Scolopendra 8-12 part, Pheretima 5-8 part, Radix Angelicae Sinensis 8-13 according to weight portion meter
Part, Radix Aconiti 15-18 part, Myrrha 13-16 part, Radix Aconiti Lateralis Preparata 14-20 part, Fructus Evodiae 9-12 part, Rhizoma Curcumae 7-12
Part, Pollen Typhae 5-8 part, Rhizoma Chuanxiong 5-10 part, Flos Lonicerae 8-11 part, Radix Astragali 6-10 part, Cortex Moutan 5-8 part,
Radix Paeoniae Rubra 18-23 part and Radix Glycyrrhizae 10-14 part.
3. the preparation method of the Chinese medicine composition treating cerebral thrombosis, it is characterised in that described preparation method bag
Include the following step:
Step 1: first by Chinese crude drug Scorpio, Scolopendra, Pheretima, Radix Angelicae Sinensis, Radix Aconiti, Myrrha, Radix Aconiti Lateralis Preparata, Wu Zhu
Cornel, Rhizoma Curcumae, Pollen Typhae, Rhizoma Chuanxiong, Flos Lonicerae, the Radix Astragali, Cortex Moutan, Radix Paeoniae Rubra and Radix Glycyrrhizae are respectively washed, remove impurity,
It is dried, then according to weight portion weighs successively, adds relative to Chinese crude drug weight 8-12 times after pulverizing
The ethanol that volumetric concentration is 40-80%, impregnate 1-2h, reflux, extract, 2-3 time, merging filtrate, retain filter
Slag, obtains alcohol extraction concentrated solution；
Step 2: by adding water in above-mentioned filtering residue, soak 15-30 minute, decoct 2 times, merge decoction liquor,
Obtain water extracting liquid；
Step 3: the water extracting liquid mix homogeneously that alcohol extraction concentrated solution step 1 obtained and step 2 obtain,
It is concentrated to give powdered extract, pulverizes, sieve, add adjuvant and make Chinese medicine.
A kind of Chinese medicine composition preparation method treating cerebral thrombosis the most according to claim 3, its feature
It is: first described Myrrha is picked up clean remove impurity, is broken into little granule or corase meal, then by Rhizoma Cyperi
Powder be placed in pot first with slow fire fry, after fry with high heat, place into Myrrha after making popular and stir, fry to dense smoke rise,
In taupe, foam crisp, take out, dry in the air cool.
A kind of Chinese medicine composition preparation method treating cerebral thrombosis the most according to claim 3, its feature
It is: in described step 3, the mixing temperature of alcohol extraction concentrated solution and water extracting liquid is 50-65 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610321722.6A CN105749189A (en) | 2016-05-13 | 2016-05-13 | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of traditional Chinese medicine composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610321722.6A CN105749189A (en) | 2016-05-13 | 2016-05-13 | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of traditional Chinese medicine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105749189A true CN105749189A (en) | 2016-07-13 |
Family
ID=56322981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610321722.6A Pending CN105749189A (en) | 2016-05-13 | 2016-05-13 | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of traditional Chinese medicine composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105749189A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106266975A (en) * | 2016-09-07 | 2017-01-04 | 广东伊茗药业有限公司 | A kind of medicine of the treatment cerebral thrombosis containing Rhizoma Acori Graminei |
| CN108299348A (en) * | 2018-02-09 | 2018-07-20 | 广东药科大学 | A kind of purposes of moutan bark carbon new natural product in preparing anticoagulation medicine |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055816A (en) * | 2015-08-25 | 2015-11-18 | 崔新明 | Traditional Chinese medicine composite for treating cerebral thrombosis and preparation method thereof |
| CN105194299A (en) * | 2015-11-12 | 2015-12-30 | 青岛华之草医药科技有限公司 | Application of traditional Chinese medicine composition in preparation of medicines for treating cerebral thrombosis |
| CN105395911A (en) * | 2016-01-11 | 2016-03-16 | 于建波 | Traditional Chinese medicine for curing cerebral thrombosis |
-
2016
- 2016-05-13 CN CN201610321722.6A patent/CN105749189A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055816A (en) * | 2015-08-25 | 2015-11-18 | 崔新明 | Traditional Chinese medicine composite for treating cerebral thrombosis and preparation method thereof |
| CN105194299A (en) * | 2015-11-12 | 2015-12-30 | 青岛华之草医药科技有限公司 | Application of traditional Chinese medicine composition in preparation of medicines for treating cerebral thrombosis |
| CN105395911A (en) * | 2016-01-11 | 2016-03-16 | 于建波 | Traditional Chinese medicine for curing cerebral thrombosis |
Non-Patent Citations (1)
| Title |
|---|
| 金龙学等: "《中西医结合治疗75例脑梗塞临床疗效观察》", 《中医药学报》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106266975A (en) * | 2016-09-07 | 2017-01-04 | 广东伊茗药业有限公司 | A kind of medicine of the treatment cerebral thrombosis containing Rhizoma Acori Graminei |
| CN108299348A (en) * | 2018-02-09 | 2018-07-20 | 广东药科大学 | A kind of purposes of moutan bark carbon new natural product in preparing anticoagulation medicine |
| CN108299348B (en) * | 2018-02-09 | 2021-06-22 | 广东药科大学 | Application of cortex moutan charcoal natural product in preparation of anticoagulant |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
| CN102319327B (en) | Traditional Chinese medicine for internally and externally treating diabetic foot | |
| CN105412893A (en) | Jingutong spray and making method thereof | |
| CN103656238A (en) | Traditional Chinese medicine composition for treating rheumatic bone diseases | |
| CN104940796A (en) | Traditional Chinese medicine composition for promoting blood circulation to remove blood stasis and relieving swelling and pain | |
| CN103908545B (en) | Drug for treating cervical and lumbar vertebra and knee hyperosteogeny and lumbar disc herniation | |
| CN100512847C (en) | Chinese traditional medicine compound took orally for treating cervical spondylosis | |
| CN106421649A (en) | Traditional Chinese medicine composition for treating cerebral apoplexy and preparation method thereof | |
| CN105709021A (en) | Muscle and bone recovery unguent and preparation method thereof | |
| CN1628760A (en) | Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease | |
| CN104815295A (en) | Traditional Chinese medicine preparation for treating cervical spondylosis | |
| CN100525815C (en) | A medicinal wine capable of treating multiple diseases | |
| CN104173773A (en) | Preparation with functions of treating migraine, dispelling wind and promoting blood circulation and preparation methods | |
| CN103432542A (en) | Medicine for preventing stroke and treating stroke sequela, and preparation method of medicine | |
| CN105749189A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of traditional Chinese medicine composition | |
| CN103736017A (en) | Traditional Chinese medicine composition for treating intercostal neuralgia and preparation method of traditional Chinese medicine composition | |
| CN104623376B (en) | Be used for the treatment of prosopalgic medicine | |
| CN105943705A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN104758527A (en) | Traditional Chinese medicine composition for treating pain in waists and legs | |
| CN104971241A (en) | Traditional Chinese medicinal composition for treating cerebral thrombus, and preparation method thereof | |
| CN103784879A (en) | Compound traditional Chinese medicinal preparation for treating ischemic cerebrovascular diseases | |
| CN107261055A (en) | A kind of Chinese medicine composition and preparation method for being used to treat dysmenorrheal caused by qi stagnation and blood stasis | |
| CN106344680A (en) | Traditional Chinese medicinal composition with effects of expelling wind and relieving cold-aggravated arthralgia and preparation method thereof | |
| CN106729101B (en) | Traditional Chinese medicine composition for treating post-circulation ischemic stroke and preparation method thereof | |
| CN105288298A (en) | Traditional Chinese medicine preparation for treating cerebral aneurysm sequelae and preparation method of traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160713 |
|
| RJ01 | Rejection of invention patent application after publication |